WST - West Pharmaceutical Services, Inc.
Close
313.63
-1.160 -0.370%
Share volume: 590,457
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$314.79
-1.16
-0.37%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-27 | 2023-02-21 | 2023-04-27 | 2023-07-27 | 2023-10-26 | 2024-02-20 | 2024-04-25 | 2024-07-25 | |
| Total revenue | 686.900 M | 708.700 M | 716.600 M | 753.800 M | 747.400 M | 732.000 M | 695.400 M | 702.100 M | |
| Cost of revenue | 418.900 M | 446.600 M | 445.300 M | 462.400 M | 459.100 M | 453.800 M | 465.200 M | 472.100 M | |
| Gross profit | 268.000 M | 262.100 M | 271.300 M | 291.400 M | 288.300 M | 278.200 M | 230.200 M | 230.000 M | |
| -2.20% | 3.51% | 7.41% | -1.06% | -3.50% | -17.25% | -0.09% | |||
| Operating expenses | 79.900 M | 101.600 M | 103.100 M | 104.900 M | 105.400 M | 108.400 M | 104.300 M | 100.500 M | |
| Selling general and admin | 66.300 M | 85.700 M | 86.000 M | 88.400 M | 89.000 M | 90.000 M | 86.700 M | 83.000 M | |
| Research and development | 13.600 M | 15.900 M | 17.100 M | 16.500 M | 16.400 M | 18.400 M | 17.600 M | 17.500 M | |
| Total expenses | 498.800 M | 548.200 M | 548.400 M | 567.300 M | 564.500 M | 562.200 M | 569.500 M | 572.600 M | |
| 9.90% | 0.04% | 3.45% | -0.49% | -0.41% | 1.30% | 0.54% | |||
| Operating income | 188.100 M | 160.500 M | 168.200 M | 186.500 M | 182.900 M | 169.800 M | 125.900 M | 129.500 M | |
| Ebit | 192.900 M | 163.700 M | 173.900 M | 191.500 M | 186.600 M | 173.100 M | 130.200 M | 134.000 M | |
| Pretax income | 141.000 M | 131.900 M | 163.600 M | 189.900 M | 190.700 M | 171.500 M | 131.700 M | 133.200 M | |
| -6.45% | 24.03% | 16.08% | 0.42% | -10.07% | -23.21% | 1.14% | |||
| Income tax | 20.400 M | 28.900 M | 23.600 M | 34.800 M | 29.400 M | 34.500 M | 16.400 M | 21.900 M | |
| Net income basic | 120.600 M | 103.000 M | 140.000 M | 155.100 M | 161.300 M | 137.000 M | 115.300 M | 111.300 M | |
| -14.59% | 35.92% | 10.79% | 4.00% | -15.07% | -15.84% | -3.47% | |||
| Net income | 120.600 M | 103.000 M | 140.000 M | 155.100 M | 161.300 M | 137.000 M | 115.300 M | 111.300 M | |
| -14.59% | 35.92% | 10.79% | 4.00% | -15.07% | -15.84% | -3.47% |